ADCETRIS Trademark

Trademark Overview

On Thursday, April 28, 2011, a trademark application was filed for ADCETRIS with the United States Patent and Trademark Office. The USPTO has given the ADCETRIS trademark a serial number of 85307761. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, March 28, 2023. This trademark is owned by Seattle Genetics, Inc.. The ADCETRIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of disorders of the immune system; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology
adcetris

General Information

Serial Number85307761
Word MarkADCETRIS
Filing DateThursday, April 28, 2011
Status800 - REGISTERED AND RENEWED
Status DateTuesday, March 28, 2023
Registration Number4133078
Registration DateTuesday, April 24, 2012
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 19, 2011

Trademark Statements

Description of MarkThe mark consists of a single, continuous looping line twisted to form a tri-lobed three-dimensional shape, with a spherical element shown above and between the two upper lobes, followed by the word "ADCETRIS".
Goods and ServicesPharmaceutical preparations for the prevention and treatment of disorders of the immune system; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 4, 2011
Primary Code005
First Use Anywhere DateMonday, August 22, 2011
First Use In Commerce DateMonday, August 22, 2011

Trademark Owner History

Party NameSEAGEN INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressBOTHELL, WA 98021
Party NameSeattle Genetics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBothell, WA 98021
Party NameSeattle Genetics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBothell, WA 98021
Party NameSeattle Genetics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBothell, WA 98021

Trademark Events

Event DateEvent Description
Tuesday, July 19, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, May 2, 2011NEW APPLICATION ENTERED
Wednesday, May 4, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 5, 2011NOTICE OF DESIGN SEARCH CODE MAILED
Friday, June 3, 2011ASSIGNED TO EXAMINER
Tuesday, June 7, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 8, 2011ASSIGNED TO LIE
Friday, June 10, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, July 19, 2011PUBLISHED FOR OPPOSITION
Friday, February 17, 2012STATEMENT OF USE PROCESSING COMPLETE
Friday, August 19, 2011EXTENSION OF TIME TO OPPOSE RECEIVED
Friday, September 9, 2011EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, October 25, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, January 23, 2012TEAS STATEMENT OF USE RECEIVED
Monday, January 23, 2012SOU TEAS EXTENSION RECEIVED
Monday, January 23, 2012SOU EXTENSION 1 FILED
Monday, January 23, 2012USE AMENDMENT FILED
Friday, February 17, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 17, 2012SOU EXTENSION 1 GRANTED
Thursday, June 7, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, February 18, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 15, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, March 17, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, March 20, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 24, 2012REGISTERED-PRINCIPAL REGISTER
Monday, April 24, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, May 25, 2018TEAS SECTION 8 & 15 RECEIVED
Thursday, June 7, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, June 7, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, January 13, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, August 13, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 13, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 13, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, August 13, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 13, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, April 24, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, April 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 15, 2022TEAS SECTION 8 & 9 RECEIVED
Tuesday, March 28, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, March 28, 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, March 28, 2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, March 28, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, May 22, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 22, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 22, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 11, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 11, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 11, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 11, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, July 11, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

adcetris pharmaceutical preparations treatment cancer oncology system disorders prevention immune